Showing results (271-280 of 724) with videos related to
Sort By:
Pageof 73
Journal of Clinical Pharmacy and Therapeutics|April 26, 2006
Developing and implementing a model for changing physicians' prescribing habits-- the role of clinical pharmacy in leading the changeE Schwartzberg, S Rubinovich, D Hassin, et al.Biochemical and Biophysical Research Communications|April 17, 2010
Raman imaging of cell wall polymers in Arabidopsis thalianaMartin Schmidt, Adam M Schwartzberg, Andrew Carroll, et al.European Journal of Immunology|September 12, 2014
T/B-cell interactions are more transient in response to weak stimuli in SLE-prone miceParisa Sinai, Igor M Dozmorov, Ran Song, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 22, 2013
Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV)Lee Schwartzberg, Sally Y Barbour, Gary R Morrow, et al.Diseases of the Colon and Rectum|October 23, 2018
Aspects of the Natural History of Sessile Serrated Adenomas/Polyps: Risk Indicators for Carcinogenesis in the Colorectal Mucosa?Peter M Neary, David M Schwartzberg, Turgot Bora Cengiz, et al.Gynecologic Oncology|September 11, 2012
Phase II clinical trial of bevacizumab with albumin-bound paclitaxel in patients with recurrent, platinum-resistant primary epithelial ovarian or primary peritoneal carcinomaTodd D Tillmanns, M Patrick Lowe, Mark S Walker, et al.Scientific Reports|July 16, 2020
Characterizing transition-metal dichalcogenide thin-films using hyperspectral imaging and machine learningBrian Shevitski, Christopher T Chen, Christoph Kastl, et al.Nanotechnology|May 11, 2023
Transferable nano-patterned ALD membraneFarhana Anwar, Matthew Tao, Adam Schwartzberg, et al.Biochemical and Biophysical Research Communications|June 15, 1989
High and low affinity binding sites for endothelin on cultured rat glomerular mesangial cellsK F Badr, K A Munger, M Sugiura, et al.Clinical Breast Cancer|December 14, 2011
Phase II multicenter trial of albumin-bound paclitaxel and capecitabine in first-line treatment of patients with metastatic breast cancerLee S Schwartzberg, Francis P Arena, David M Mintzer, et al.Pageof 73